Aug 26, 20202 min read
Hello from our new imaging core lab
Resoundant Expands Services Offerings to Support Use of Quantitative Imaging Biomarkers in Clinical Trials Kay Pepin, PhD is Manager,...
Aug 20, 20203 min read
It’s official – we’re in the core lab business
Resoundant Expands Services Offerings to Support Use of Quantitative Imaging Biomarkers in Clinical Trials Resoundant, Inc. announced...
Aug 18, 20201 min read
MRE Top Noninvasive Test for Confirming NASH Fibrosis
Abstract Background: There has been an increased interest in the use of noninvasive tests (NITs) to identify advanced liver fibrosis in...
Aug 12, 20203 min read
Resoundant Expands Its Research Services Footprint
Company to offer advanced MRE and PDFF biomarkers for NAFLD/NASH clinical trials
Apr 23, 20203 min read
Resoundant Appoints Roderic I. Pettigrew to Board of Directors
Rochester, MN, USA—Resoundant, Inc. announced today the appointment of Roderic I. Pettigrew, MD, PhD to its Board of Directors. "We’re...
Mar 30, 20201 min read
Statement from Resoundant CEO Richard Ehman, MD on the COVID-19 Outbreak
Rochester, MN, USA— The COVID-19 pandemic is creating extraordinary challenges for our families, healthcare systems, and society as a...